{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:32:31Z","timestamp":1780410751707,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol. Sin."],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12250-021-00454-z","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T06:06:16Z","timestamp":1633932376000},"page":"1600-1610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Identification and Characterization of a Novel Single Domain Antibody Against Ebola Virus"],"prefix":"10.1016","volume":"36","author":[{"given":"Rui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8161-3949","authenticated-orcid":false,"given":"Huajun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9222-5642","authenticated-orcid":false,"given":"Rui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"454_CR1","doi-asserted-by":"publisher","first-page":"586595","DOI":"10.3389\/fimmu.2020.586595","volume":"11","author":"V Agnolon","year":"2020","unstructured":"Agnolon V, Kiseljak D, Wurm MJ, Wurm FM, Foissard C, Gallais F, Wehrle S, Mu\u00f1oz-Fontela C, Bellanger L, Correia BE, Corradin G, Spertini F (2020) Designs and characterization of subunit Ebola GP vaccine candidates: implications for immunogenicity. Front Immunol 11:586595","journal-title":"Front Immunol"},{"key":"454_CR2","doi-asserted-by":"publisher","first-page":"1689027","DOI":"10.1080\/19420862.2019.1689027","volume":"12","author":"G Cao","year":"2020","unstructured":"Cao G, Gao X, Zhan Y, Wang Q, Zhang Z, Dimitrov DS, Gong R (2020) An engineered human IgG1 CH2 domain with decreased aggregation and nonspecific binding. Mabs 12:1689027","journal-title":"Mabs"},{"key":"454_CR3","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.aad5224","volume":"351","author":"D Corti","year":"2016","unstructured":"Corti D, Misasi J, Mulangu S, Stanley DA, Kanekiyo M, Wollen S, Ploquin A, Doria-Rose NA, Staupe RP, Bailey M, Shi W, Choe M, Marcus H, Thompson EA, Cagigi A, Silacci C, Fernandez-Rodriguez B, Perez L, Sallusto F, Vanzetta F, Agatic G, Cameroni E, Kisalu N, Gordon I, Ledgerwood JE, Mascola JR, Graham BS, Muyembe-Tamfun JJ, Trefry JC, Lanzavecchia A, Sullivan NJ (2016) Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science 351:1339\u20131342","journal-title":"Science"},{"key":"454_CR4","doi-asserted-by":"publisher","first-page":"e3000626","DOI":"10.1371\/journal.pbio.3000626","volume":"18","author":"DK Das","year":"2020","unstructured":"Das DK, Bulow U, Diehl WE, Durham ND, Senjobe F, Chandran K, Luban J, Munro JB (2020) Conformational changes in the Ebola virus membrane fusion machine induced by pH, Ca2+, and receptor binding. PLoS Biol 18:e3000626","journal-title":"PLoS Biol"},{"key":"454_CR5","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","volume":"375","author":"RT Davey","year":"2016","unstructured":"Davey RT, Dodd L, Proschan MA, Neaton J, Neuhaus Nordwall J, Koopmeiners JS, Beigel J, Tierney J, Lane HC, Fauci AS, Massaquoi MBF, Sahr F, Malvy D (2016) A randomized, controlled trial of ZMapp for Ebola virus infection. N Engl J Med 375:1448\u20131456","journal-title":"N Engl J Med"},{"key":"454_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1128\/AAC.01802-15","volume":"60","author":"L Detalle","year":"2016","unstructured":"Detalle L, Stohr T, Palomo C, Piedra PA, Gilbert BE, Mas V, Millar A, Power UF, Stortelers C, Allosery K, Melero JA, Depla E (2016) Generation and characterization of ALX-0171, a potent novel therapeutic nanobody for the treatment of respiratory syncytial virus infection. Antimicrob Agents Chemother 60:6\u201313","journal-title":"Antimicrob Agents Chemother"},{"key":"454_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4161\/mabs.1.1.7480","volume":"1","author":"DS Dimitrov","year":"2009","unstructured":"Dimitrov DS (2009) Engineered CH2 domains (nanoantibodies). Mabs 1:26\u201328","journal-title":"Mabs"},{"key":"454_CR8","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s40265-018-0989-0","volume":"78","author":"S Duggan","year":"2018","unstructured":"Duggan S (2018) Caplacizumab: First Global Approval. Drugs 78:1639\u20131642","journal-title":"Drugs"},{"key":"454_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/bs.aivir.2017.12.002","volume":"100","author":"J Emanuel","year":"2018","unstructured":"Emanuel J, Marzi A, Feldmann H (2018) Filoviruses: ecology, molecular biology, and evolution. Adv Virus Res 100:189\u2013221","journal-title":"Adv Virus Res"},{"key":"454_CR10","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1021\/acs.molpharmaceut.9b00544","volume":"16","author":"X Gao","year":"2019","unstructured":"Gao X, Conard A, Yang C, Zhan Y, Zeng F, Shi J, Li W, Dimitrov DS, Gong R (2019) Optimization of the C-terminus of an autonomous human IgG1 CH2 domain for stability and aggregation resistance. Mol Pharm 16:3647\u20133656","journal-title":"Mol Pharm"},{"key":"454_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4155\/ppa.13.44","volume":"2","author":"R Gong","year":"2013","unstructured":"Gong R, Xiao G (2013) Engineered antibody variable and constant domains as therapeutic candidates. Pharm Pat Anal 2:637\u2013646","journal-title":"Pharm Pat Anal"},{"key":"454_CR12","doi-asserted-by":"publisher","first-page":"14203","DOI":"10.1074\/jbc.M900769200","volume":"284","author":"R Gong","year":"2009","unstructured":"Gong R, Vu BK, Feng Y, Prieto DA, Dyba MA, Walsh JD, Prabakaran P, Veenstra TD, Tarasov SG, Ishima R, Dimitrov DS (2009) Engineered human antibody constant domains with increased stability. J Biol Chem 284:14203\u201314210","journal-title":"J Biol Chem"},{"key":"454_CR13","doi-asserted-by":"publisher","first-page":"27288","DOI":"10.1074\/jbc.M111.254219","volume":"286","author":"R Gong","year":"2011","unstructured":"Gong R, Wang Y, Feng Y, Zhao Q, Dimitrov DS (2011) Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal Fc receptor. J Biol Chem 286:27288\u201327293","journal-title":"J Biol Chem"},{"key":"454_CR14","doi-asserted-by":"publisher","first-page":"e42288","DOI":"10.1371\/journal.pone.0042288","volume":"7","author":"R Gong","year":"2012","unstructured":"Gong R, Wang Y, Ying T, Dimitrov DS (2012) Bispecific engineered antibody domains (nanoantibodies) that interact noncompetitively with an HIV-1 neutralizing epitope and FcRn. PLoS ONE 7:e42288","journal-title":"PLoS ONE"},{"key":"454_CR15","doi-asserted-by":"publisher","first-page":"11211","DOI":"10.1073\/pnas.1104760108","volume":"108","author":"SM Gregory","year":"2011","unstructured":"Gregory SM, Harada E, Liang B, Delos SE, White JM, Tamm LK (2011) Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2. Proc Natl Acad Sci USA 108:11211\u201311216","journal-title":"Proc Natl Acad Sci USA"},{"key":"454_CR16","doi-asserted-by":"crossref","unstructured":"Karan LS, Makenov MT, Korneev MG, Sacko N, Boumbaly S, Yakovlev SA, Kourouma K, Bayandin RB, Gladysheva AV, Shipovalov AV, Yurganova IA, Grigorieva YE, Fedorova MV, Scherbakova SA, Kutyrev VV, Agafonov AP, Maksyutov RA, Shipulin GA, Maleev VV, Boiro M, Akimkin VG, Popova AY (2019) Bombali virus in mops condylurus bats, Guinea. Emerg Infect Dis 25:1774\u20131775","DOI":"10.3201\/eid2509.190581"},{"key":"454_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.molimm.2015.01.010","volume":"65","author":"F Kazemi-Lomedasht","year":"2015","unstructured":"Kazemi-Lomedasht F, Behdani M, Bagheri KP, Habibi-Anbouhi M, Abolhassani M, Arezumand R, Shahbazzadeh D, Mirzahoseini H (2015) Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody. Mol Immunol 65:58\u201367","journal-title":"Mol Immunol"},{"key":"454_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1128\/JVI.02172-15","volume":"90","author":"Z-Y Keck","year":"2016","unstructured":"Keck Z-Y, Enterlein SG, Howell KA, Vu H, Shulenin S, Warfield KL, Froude JW, Araghi N, Douglas R, Biggins J, Lear-Rooney CM, Wirchnianski AS, Lau P, Wang Y, Herbert AS, Dye JM, Glass PJ, Holtsberg FW, Foung SKH, Aman MJ (2016) Macaque monoclonal antibodies targeting novel conserved epitopes within filovirus glycoprotein. J Virol 90:279\u2013291","journal-title":"J Virol"},{"key":"454_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature07082","volume":"454","author":"JE Lee","year":"2008","unstructured":"Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, Saphire EO (2008) Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454:177\u2013182","journal-title":"Nature"},{"key":"454_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s40265-020-01452-3","volume":"81","author":"A Markham","year":"2021","unstructured":"Markham A (2021) REGN-EB3: first approval. Drugs 81:175\u2013178","journal-title":"Drugs"},{"key":"454_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/infdis\/jiy532","volume":"219","author":"JC Milligan","year":"2019","unstructured":"Milligan JC, Parekh DV, Fuller KM, Igarashi M, Takada A, Saphire EO (2019) Structural characterization of pan-Ebolavirus antibody 6D6 targeting the fusion peptide of the surface glycoprotein. J Infect Dis 219:415\u2013419","journal-title":"J Infect Dis"},{"key":"454_CR22","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.aad6117","volume":"351","author":"J Misasi","year":"2016","unstructured":"Misasi J, Gilman MS, Kanekiyo M, Gui M, Cagigi A, Mulangu S, Corti D, Ledgerwood JE, Lanzavecchia A, Cunningham J, Muyembe-Tamfun JJ, Baxa U, Graham BS, Xiang Y, Sullivan NJ, McLellan JS (2016) Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science 351:1343\u20131346","journal-title":"Science"},{"key":"454_CR23","doi-asserted-by":"crossref","unstructured":"Mulangu S, Dodd LE, Davey RT Jr, Tshiani Mbaya O, Proschan M, Mukadi D, Lusakibanza Manzo M, Nzolo D, Tshomba Oloma A, Ibanda A, Ali R, Coulibaly S, Levine AC, Grais R, Diaz J, Lane HC, Muyembe-Tamfum JJ, Group PW, Sivahera B, Camara M, Kojan R, Walker R, Dighero-Kemp B, Cao H, Mukumbayi P, Mbala-Kingebeni P, Ahuka S, Albert S, Bonnett T, Crozier I, Duvenhage M, Proffitt C, Teitelbaum M, Moench T, Aboulhab J, Barrett K, Cahill K, Cone K, Eckes R, Hensley L, Herpin B, Higgs E, Ledgerwood J, Pierson J, Smolskis M, Sow Y, Tierney J, Sivapalasingam S, Holman W, Gettinger N, Vallee D, Nordwall J, Team PCS (2019) A randomized, controlled trial of ebola virus disease therapeutics. N Engl J Med 381:2293\u20132303","DOI":"10.1056\/NEJMoa1910993"},{"key":"454_CR24","doi-asserted-by":"crossref","unstructured":"Negredo A, Palacios G, V\u00e1zquez-Mor\u00f3n S, Gonz\u00e1lez F, Dopazo H, Molero F, Juste J, Quetglas J, Savji N, de la Cruz Mart\u00ednez M, Herrera JE, Pizarro M, Hutchison SK, Echevarr\u00eda JE, Lipkin WI, Tenorio A (2011) Discovery of an ebolavirus-like filovirus in europe. PLoS Pathog 7:e1002304","DOI":"10.1371\/journal.ppat.1002304"},{"key":"454_CR25","doi-asserted-by":"publisher","first-page":"16128","DOI":"10.1038\/nmicrobiol.2016.128","volume":"1","author":"J Pallesen","year":"2016","unstructured":"Pallesen J, Murin CD, de Val N, Cottrell CA, Hastie KM, Turner HL, Fusco ML, Flyak AI, Zeitlin L, Crowe JE Jr, Andersen KG, Saphire EO, Ward AB (2016) Structures of Ebola virus GP and sGP in complex with therapeutic antibodies. Nat Microbiol 1:16128","journal-title":"Nat Microbiol"},{"key":"454_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.clim.2011.08.008","volume":"141","author":"X Qiu","year":"2011","unstructured":"Qiu X, Alimonti JB, Melito PL, Fernando L, Stroher U, Jones SM (2011) Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. Clin Immunol 141:218\u2013227","journal-title":"Clin Immunol"},{"key":"454_CR27","doi-asserted-by":"crossref","unstructured":"Qiu X, Audet J, Wong G, Pillet S, Bello A, Cabral T, Strong JE, Plummer F, Corbett CR, Alimonti JB, Kobinger GP (2012) Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med 4:138ra181","DOI":"10.1126\/scitranslmed.3003876"},{"key":"454_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature13777","volume":"514","author":"X Qiu","year":"2014","unstructured":"Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly MH, Velasco J, Pettitt J, Olinger GG, Whaley K, Xu B, Strong JE, Zeitlin L, Kobinger GP (2014) Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514:47\u201353","journal-title":"Nature"},{"key":"454_CR29","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1093\/infdis\/jir622","volume":"204","author":"B Schepens","year":"2011","unstructured":"Schepens B, Ibanez LI, De Baets S, Hultberg A, Bogaert P, De Bleser P, Vervalle F, Verrips T, Melero J, Vandevelde W, Vanlandschoot P, Saelens X (2011) Nanobodies(R) specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion. J Infect Dis 204:1692\u20131701","journal-title":"J Infect Dis"},{"key":"454_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cell.2015.12.044","volume":"164","author":"H Wang","year":"2016","unstructured":"Wang H, Shi Y, Song J, Qi J, Lu G, Yan J, Gao GF (2016) Ebola viral glycoprotein bound to its endosomal receptor Niemann-Pick C1. Cell 164:258\u2013268","journal-title":"Cell"},{"key":"454_CR31","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, Heer FT, de Beer TAP, Rempfer C, Bordoli L, Lepore R, Schwede T (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46:W296\u2013W303","journal-title":"Nucleic Acids Res"},{"key":"454_CR32","doi-asserted-by":"crossref","unstructured":"Wec AZ, Herbert AS, Murin CD, Nyakatura EK, Abelson DM, Fels JM, He S, James RM, de La Vega M-A, Zhu W, Bakken RR, Goodwin E, Turner HL, Jangra RK, Zeitlin L, Qiu X, Lai JR, Walker LM, Ward AB, Dye JM, Chandran K, Bornholdt ZA (2017) Antibodies from a human survivor define sites of vulnerability for broad protection against ebolaviruses. Cell 169","DOI":"10.1016\/j.cell.2017.04.037"},{"key":"454_CR33","doi-asserted-by":"publisher","first-page":"5722","DOI":"10.1016\/j.vaccine.2014.08.028","volume":"32","author":"G Wong","year":"2014","unstructured":"Wong G, Audet J, Fernando L, Fausther-Bovendo H, Alimonti JB, Kobinger GP, Qiu X (2014) Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents. Vaccine 32:5722\u20135729","journal-title":"Vaccine"},{"key":"454_CR34","doi-asserted-by":"crossref","unstructured":"Wu Y, Li C, Xia S, Tian X, Kong Y, Wang Z, Gu C, Zhang R, Tu C, Xie Y, Yang Z, Lu L, Jiang S, Ying T (2020) Identification of human single-domain antibodies against SARS-CoV-2. Cell Host Microbe 27:891\u2013898 e895","DOI":"10.1016\/j.chom.2020.04.023"},{"key":"454_CR35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.bbrc.2009.07.044","volume":"387","author":"X Xiao","year":"2009","unstructured":"Xiao X, Feng Y, Vu BK, Ishima R, Dimitrov DS (2009) A large library based on a novel (CH2) scaffold: identification of HIV-1 inhibitors. Biochem Biophys Res Commun 387:387\u2013392","journal-title":"Biochem Biophys Res Commun"},{"key":"454_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jmb.2003.09.055","volume":"335","author":"MY Zhang","year":"2004","unstructured":"Zhang MY, Shu Y, Rudolph D, Prabakaran P, Labrijn AF, Zwick MB, Lal RB, Dimitrov DS (2004) Improved breadth and potency of an HIV-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning. J Mol Biol 335:209\u2013219","journal-title":"J Mol Biol"},{"key":"454_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nature18615","volume":"535","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Ren J, Harlos K, Jones DM, Zeltina A, Bowden TA, Padilla-Parra S, Fry EE, Stuart DI (2016) Toremifene interacts with and destabilizes the Ebola virus glycoprotein. Nature 535:169\u2013172","journal-title":"Nature"},{"key":"454_CR38","doi-asserted-by":"crossref","unstructured":"Zhao X, Howell KA, He S, Brannan JM, Wec AZ, Davidson E, Turner HL, Chiang C-I, Lei L, Fels JM, Vu H, Shulenin S, Turonis AN, Kuehne AI, Liu G, Ta M, Wang Y, Sundling C, Xiao Y, Spence JS, Doranz BJ, Holtsberg FW, Ward AB, Chandran K, Dye JM, Qiu X, Li Y, Aman MJ (2017) Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability. Cell 169:891\u2013904.e15","DOI":"10.1016\/j.cell.2017.04.038"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12250-021-00454-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12250-021-00454-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12250-021-00454-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T06:37:53Z","timestamp":1641278273000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12250-021-00454-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["454"],"URL":"https:\/\/doi.org\/10.1007\/s12250-021-00454-z","relation":{},"ISSN":["1674-0769","1995-820X"],"issn-type":[{"value":"1674-0769","type":"print"},{"value":"1995-820X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"5 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest with the contents of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal and Human Rights Statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}